Although this truly remarkable Australian biotech is relatively unknown, the future is so promising. It will not be too much longer before a vast majority of funds and individuals finally discover the endless possibilities Starpharma has to offer.
I also believe that we will not be taken over, because the global commercialisation of Viva Gel will act as a rent roll to fund all the relevant procedures we have in the pipeline.
What a truly remarkable time to be a holder of SPL.
Very interesting article, page-11
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |